Technical Analysis for BHVN - Biohaven Pharmaceutical Holding Company Ltd.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Down | Up |
Date | Alert Name | Type | % Chg |
---|
Alert | Time |
---|---|
No Alerts Yet. Alerts will only show here if at least one person is tracking alerts on this stock. |
Get this analysis on your stocks daily!
- Earnings date: 05/10/2024
Biohaven Pharmaceutical Holding Company Ltd. Description
Biohaven Pharmaceutical Holding Company Ltd. is a United States-based biopharmaceutical company. The Company is engaged in the identification and development of clinical-stage compounds targeting orphan neurologic indications and other neurological pathways. It has a portfolio of multiple late-stage drug candidates. Its pipeline includes BHV-0223, which is a formulation of a glutamate-modulating agent; BHV-4157, which is a new chemical entity (NCE) that modulates glutamate, and BHV-5000, which is an in-licensed investigational agent of the Company targeting N-Methyl-D-Aspartate (NMDA) receptor antagonism. Its clinical compound, trigriluzole, is indicated for neurodegenerative diseases and cancer indications, among others. Its pipeline also includes BHV-3000 and BHV-3500, which are in-licensed by the Company for a neurologic indication. It focuses on advancing other mechanistic approaches in orphan and neuroscience indications, and is exploring licenses for additional compounds.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Cancer Neuroscience Organic Compounds Chemical Compounds Neurodegenerative Diseases Glutamate Neurotransmitters Chemical Entity N Methyl D Aspartic Acid Riluzole
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 62.21 |
52 Week Low | 14.19 |
Average Volume | 1,428,802 |
200-Day Moving Average | 36.46 |
50-Day Moving Average | 47.32 |
20-Day Moving Average | 38.90 |
10-Day Moving Average | 38.44 |
Average True Range | 2.86 |
RSI (14) | 39.76 |
ADX | 20.42 |
+DI | 22.02 |
-DI | 29.05 |
Chandelier Exit (Long, 3 ATRs) | 34.74 |
Chandelier Exit (Short, 3 ATRs) | 42.17 |
Upper Bollinger Bands | 42.75 |
Lower Bollinger Band | 35.04 |
Percent B (%b) | 0.3 |
BandWidth | 19.82 |
MACD Line | -2.53 |
MACD Signal Line | -2.76 |
MACD Histogram | 0.2278 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 40.51 | ||||
Resistance 3 (R3) | 40.72 | 39.88 | 39.99 | ||
Resistance 2 (R2) | 39.88 | 39.08 | 39.77 | 39.81 | |
Resistance 1 (R1) | 38.62 | 38.58 | 38.20 | 38.42 | 39.64 |
Pivot Point | 37.78 | 37.78 | 37.57 | 37.68 | 37.78 |
Support 1 (S1) | 36.53 | 36.98 | 36.11 | 36.32 | 35.10 |
Support 2 (S2) | 35.69 | 36.49 | 35.58 | 34.93 | |
Support 3 (S3) | 34.43 | 35.69 | 34.75 | ||
Support 4 (S4) | 34.23 |